10-Q: Medicale Corp. Reports Net Loss for Q1 2024, Cites Going Concern Uncertainty

Medicale Corp. reports a net loss of $19,307 for the quarter ended December 31, 2023, with concerns raised about the company's ability to continue as a going concern.

Summary

• Medicale Corp. reported a net loss of $19,307 for the three months ended December 31, 2023, compared to a net loss of $8,259 for the same period in 2022.
• The company's operating expenses primarily consisted of professional fees.
• As of December 31, 2023, the company's total assets were $159, consisting entirely of cash.
• Current liabilities totaled $60,186, including $48,186 in convertible notes and $12,000 in liabilities from discontinued operations.
• The company has an accumulated deficit of $136,939 as of December 31, 2023, and expresses substantial doubt about its ability to continue as a going concern.
• Management anticipates dependence on additional investment capital to fund operating expenses.
• The company ceased its previous primary business of selling consumer products and accessories as of January 1, 2023.
• The company entered into two convertible note agreements totaling $48,186 on December 31, 2023, with an 8% interest rate and maturity in 2029.
• The company's disclosure controls and procedures were deemed not effective as of December 31, 2023.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the net loss, accumulated deficit, going concern uncertainty, and ineffective disclosure controls. The only slightly positive aspect is the securing of convertible note financing.

Positives

• The company secured $48,186 in financing through convertible notes.

Negatives

• The company reported a net loss of $19,307 for the quarter ended December 31, 2023.
• The company has an accumulated deficit of $136,939 as of December 31, 2023.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company's disclosure controls and procedures were deemed not effective as of December 31, 2023.

Risks

• The company's ability to continue as a going concern is uncertain.
• The company is dependent on raising additional capital.
• The company's disclosure controls and procedures are not effective.
• The company faces risks related to global economic disruptions, including the war between Russia and Ukraine and the conflict between Israel and Hamas.

Future Outlook

The company expects to require additional capital to meet its long-term operating requirements and intends to raise additional capital through the sale of equity or debt securities.

Management Comments

• Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses.
• Management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

Industry Context

Given the company's early stage and lack of revenue, it's difficult to draw direct comparisons. However, many early-stage companies in the dietary supplement and consulting services industries face similar challenges in securing funding and establishing a sustainable business model. Companies like NutraLife BioSciences and Klean Athlete operate in the dietary supplement space, while numerous consulting firms exist, making competition intense.

Comparison to Industry Standards

• It is difficult to compare Medicale Corp to industry standards due to its early stage and lack of revenue.
• Many companies in the dietary supplement and consulting services industries face similar challenges in securing funding and establishing a sustainable business model.
• Companies like NutraLife BioSciences and Klean Athlete operate in the dietary supplement space, while numerous consulting firms exist, making competition intense.

Management Changes

Related Party Transactions

• On December 28, 2022, the previous majority shareholder of Medicale Corp. (the Company) Borisi Alborovi forgive the debt that due to him, with the amount of $ 51,192 .

Stakeholder Impact

• Shareholders face potential dilution from future equity issuances.
• The company's ability to continue as a going concern impacts all stakeholders, including shareholders, creditors, and potential employees.

Next Steps

• The company intends to position itself so that it will be able to raise additional funds through the capital markets.
• The company will continuously evaluate the effect of global events on the Company.

Key Dates

Keywords

Medicale Corp, financial results, net loss, going concern, convertible note, disclosure controls, Q1 2024, operating expenses, accumulated deficit, liquidity